Focus
Bioinformatics Investors: Angels and VC Firms
The RaiseHunt database lists 192 Bioinformatics investors: 114 angel investors and 78 people at 19 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, Istanbul and Boston.
Strongest in San Francisco, Istanbul and Boston
- 192
- Bioinformatics investors
- 114
- Angel investors
- 78
- People at VC/PE firms
- 19
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
192 Bioinformatics investors
Showing 1-20
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Matt McIlwain Managing Director at Madrona | Seattle, United States | Angel | AIHealthcare | ||
Emily Melton Founder and Managing Partner at Threshold Ventures | Portola Valley, United States | AngelOperator angel | AIHealthcare | ||
Jonathan Hirsch Partner at Rebel Fund | San Francisco, United States | AngelOperator angel | AIHealthcare | ||
Claude Florin Principal at Venture Concept | Écublens, Switzerland | AngelOperator angel | FinTechHardware | ||
Othman Laraki Co-Founder & CEO at Color | San Francisco, United States | AngelOperator angel | AIConsumer | ||
Demis Hassabis Co-Founder & CEO at Google DeepMind | London, United Kingdom | AngelOperator angel | AIHealthcare | ||
Nathan Benaich Investing at Air Street Capital | London, United Kingdom | AngelOperator angel | AIFinTech | ||
Vinay Seth Mohta CEO & Co-founder at Manifold | Boston, United States | AngelOperator angel | AIEducation | ||
John Leonard Board Member at IQVIA | Cambridge, United States | Angel | AIHealthcare | ||
Soham Mehta angel investor and operator angel | India | AngelOperator angel | AIFinTech | ||
Naveen Jain angel investor and operator angel | Bellevue, United States | AngelOperator angel | AIConsumer | ||
Blake Borgeson angel investor and operator angel | Austin, United States | AngelOperator angel | AIHealthcare | ||
Michael Pierce angel investor | Highland Park, United States | Angel | AIFinTech | ||
Allen Day Venture Partner at Primitive Ventures | Singapore | AngelOperator angel | AIFinTech | ||
Ben Lamm angel investor and operator angel | Dallas, United States | AngelOperator angel | AIHealthcare | ||
Alon Altschuler angel investor and syndicate member | Boston, United States | AngelSyndicate / Angel group | AIHealthcare | ||
Martha Carlin angel investor and operator angel | Denver, United States | AngelOperator angel | ConsumerHealthcare | ||
Alice Zhang angel investor and operator angel | San Francisco, United States | AngelOperator angel | AIHealthcare | ||
Vic Kapur angel investor and operator angel | United States | AngelOperator angel | AIFinTech | ||
Li Sun angel investor and operator angel | San Francisco, United States | AngelOperator angel | AIFinTech |
152 of 192 Bioinformatics investors, A to Z
Grouped by first letter. Name and profile link only, the detailed rows are in the table above.ShowHide
A15
B5
C8
D16
E9
F4
G9
H2
I1
J15
K2
L3
M13
N4
O4
P6
R9
S13
T5
U1
V2
W2
Y2
Z2
Frequently asked questions
How many Bioinformatics investors are on RaiseHunt?
RaiseHunt currently lists 192 Bioinformatics investors.
Are Bioinformatics investors angels or funds?
Both. 114 are angel investors putting in their own money, and 78 are people making investment decisions at 19 firms.
Where are most Bioinformatics investors based?
The largest concentrations are in San Francisco, Istanbul and Boston.
What stage do Bioinformatics investors invest at?
Most list Seed and Series A among the rounds they take part in.
How do I contact Bioinformatics investors?
Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Bioinformatics investors free to browse?
Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.
Do Bioinformatics investors only back Bioinformatics companies?
No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.
What do investors look at first?
The team and the problem, in that order, before the product. Early on there is rarely enough traction to argue from numbers alone, so the question they are answering is whether these particular people are likely to work this problem out.
Should I raise from one investor or several?
Several, in almost every case. A single backer concentrates the risk of the round collapsing if that one conversation goes cold, and a group brings more introductions later. Rounds are usually assembled from a lead plus others who follow.
How do I follow up without being annoying?
Follow up with new information rather than a reminder. A short note saying what changed since you last wrote gives the reader a reason to reply, where "just checking in" gives them none. Two or three of those, spaced out, is normal and expected.
What if no Bioinformatics investor replies?
Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.
What is the difference between an angel investor and a VC fund?
An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal
